Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Developmental expression, co-localization and genetic interaction of exocyst component Sec15 with Rab11 during Drosophila development.

Authors:
Tanmay Bhuin Jagat K Roy

Exp Cell Res 2019 08 7;381(1):94-104. Epub 2019 May 7.

Cytogenetics Laboratory, Department of Zoology, Banaras Hindu University, Varanasi, 221 005, India.

Sec15, a component of an evolutionarily conserved octomeric exocyst complex, has been identified as an interactor of GTP-bound Rab11 in mammals and Drosophila which shows its role in secretion in yeast and intracellular vesicle transport. Here, we report the expression patterns of Drosophila Sec15 (DSec15) transcript and Sec15 protein during Drosophila development. At early embryonic stages, a profound level of maternally loaded DSec15 transcript and protein is found. At cellular blastoderm cells (stage 5 embryos); the expression is seen in pole cells, apical membrane and sub-apical region. The transcript is predominantly accumulated in mesoderm, tracheal pits, gut, LE cells, trachea, and ventral nerve cord as development proceeds. While, a robust expression of Sec15 is seen in amnioserosa (AS), lateral epidermis (LAE), developing trachea, gut, ventral nerve cord and epithelial cells. During larval development, the transcript is also found in all imaginal discs with a distinguished accumulation in the morphogenetic furrow of eye disc, gut, proventriculus and gastric ceacae, garland cells/nephrocytes, malpighian tubules, ovary and testis. Further, we show that Sec15 co-localizes with Rab11 during Drosophila embryonic and larval development. Finally, using a genetic approach, we demonstrate that Sec15 interacts with Rab11 in producing blister during Drosophila wing development.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2019.04.038DOI Listing
August 2019

Publication Analysis

Top Keywords

nerve cord
8
drosophila development
8
ventral nerve
8
larval development
8
dsec15 transcript
8
rab11 drosophila
8
sec15
7
drosophila
6
development
6
epidermis lae
4
lae developing
4
developing trachea
4
trachea gut
4
gut ventral
4
cells trachea
4
trachea ventral
4
cord development
4
expression sec15
4
sec15 amnioserosa
4
amnioserosa lateral
4

Keyword Occurance

Similar Publications

Methylmercury induces hyperalgesia/allodynia through spinal cord dorsal horn neuronal activation and subsequent somatosensory cortical circuit formation in rats.

Authors:
Masatake Fujimura Fusako Usuki Atsushi Nakamura

Arch Toxicol 2021 Apr 13. Epub 2021 Apr 13.

Department of Clinical Medicine, National Institute for Minamata Disease, Kumamoto, Japan.

Methylmercury (MeHg) is known to cause serious neurological deficits in humans. In this study, we investigated the occurrence of MeHg-mediated neuropathic pain and identified the underlying pathophysiological mechanism in a rat model of MeHg exposure. Rats were exposed to MeHg (20 ppm in drinking water) for 3 weeks. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Neuromodulation techniques for cancer pain management.

Authors:
David J Magee John Schutzer-Weissmann Erlick A C Pereira Matthew R D Brown

Curr Opin Support Palliat Care 2021 Mar 31. Epub 2021 Mar 31.

Signalling and Cancer Metabolism Team, Division of Cancer Biology, The Institute of Cancer Research Pain Medicine Department, The Royal Marsden Hospital Neurosciences Research Centre, Molecular and Clinical Sciences Institute, St George's, University of London Department of Neurosurgery, St George's University Hospital Targeted Approaches to Cancer Pain Group, The Institute of Cancer Research, London, UK.

Purpose Of Review: Advanced pain management techniques may be indicated in 5-15% of cancer patients. Despite this, a recent review identified that, over the course of 1 year in England, only 458 patients received a procedure intended to provide analgesia and only 30 patients had intrathecal drug delivery (ITDD) devices implanted. This article describes the emerging evidence for ITDD in cancer pain and provides a narrative review of other neuromodulatory techniques (including spinal cord stimulation, peripheral nerve stimulation and acupuncture), approaches that might be employed to address this area of significant unmet clinical need. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap